ArticleBioactive materials2026
ECM stiffness governs endothelial barrier integrity through YAP-mediated stabilization of ZO-1.
Article in Bioactive materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Hippo-YAP/TAZ Signaling in Astrocytes and Microglia: Role in Neuroinflammation, Neurodegeneration and Glial Tumors.International journal of molecular sciences · 2026Review
- Stability selection machine learning identifies biomechanical markers for subclinical idiopathic corneal endothelial abnormalities.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The integrity of intercellular junctions is essential for maintaining tissue barriers and preventing pathological fluid leakage. While reduced extracellular matrix (ECM) stiffness has emerged as a biomechanical trigger for barrier dysfunction, the underlying mechanotransduction mechanisms remain poorly understood. In this study, employing tunable polyacrylamide hydrogels to model physiological and pathological ECM stiffness, we demonstrate that matrix softening occurs earlier than morphological changes in corneal endothelial cells (CEnCs) and triggers junctional disassembly by impairing the membrane localization and stability of the tight junction protein ZO-1. Mechanistically, we uncover a novel non-canonical role for YAP in binding and stabilizing ZO-1, thereby shielding it from ubiquitin-proteasome degradation. Furthermore, we elucidate a synergistic interplay between FAK and Hippo signaling pathways, which converges on YAP to modulate junctional integrity in response to ECM stiffness. Computational modeling further elucidates the spatiotemporal dynamics of stress propagation during ECM softening, providing a biomechanical framework for intercellular gap formation and cell detachment. Collectively, these results establish matrix stiffness as a pivotal modulator of cell-cell junctions, yielding fresh perspectives for harnessing engineered biomaterials in the fabrication of robust tissue barriers.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.